A prospective study of the associations among fine particulate matter, genetic variants, and the risk of colorectal cancer

Background: Fine particulate matter (PM2.5) is suspected to increase the risk of colorectal cancer, but the mechanism remains unknown. We aimed to investigate the association between PM2.5 exposure, genetic variants and colorectal cancer risk in the Prostate, Lung, Colon and Ovarian (PLCO) Cancer Sc...

Full description

Bibliographic Details
Main Authors: Haiyan Chu, Junyi Xin, Qi Yuan, Yanling Wu, Mulong Du, Rui Zheng, Hanting Liu, Shaowei Wu, Zhengdong Zhang, Meilin Wang
Format: Article
Language:English
Published: Elsevier 2021-02-01
Series:Environment International
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0160412020322649
_version_ 1819054957750386688
author Haiyan Chu
Junyi Xin
Qi Yuan
Yanling Wu
Mulong Du
Rui Zheng
Hanting Liu
Shaowei Wu
Zhengdong Zhang
Meilin Wang
author_facet Haiyan Chu
Junyi Xin
Qi Yuan
Yanling Wu
Mulong Du
Rui Zheng
Hanting Liu
Shaowei Wu
Zhengdong Zhang
Meilin Wang
author_sort Haiyan Chu
collection DOAJ
description Background: Fine particulate matter (PM2.5) is suspected to increase the risk of colorectal cancer, but the mechanism remains unknown. We aimed to investigate the association between PM2.5 exposure, genetic variants and colorectal cancer risk in the Prostate, Lung, Colon and Ovarian (PLCO) Cancer Screening trial. Methods: We included a prospective cohort of 139,534 cancer-free individuals from 10 United States research centers with over ten years of follow-up. We used a Cox regression model to assess the association between PM2.5 exposure and colorectal cancer incidence by calculating the hazard ratio (HR) and 95% confidence interval (CI) with adjustment for potential confounders. The polygenic risk score (PRS) and genome-wide interaction analysis (GWIA) were used to evaluate the multiplicative interaction between PM2.5 exposure and genetic variants in regard to colorectal cancer risk. Results: After a median of 10.43 years of follow-up, 1,666 participants had been diagnosed with colorectal cancer. PM2.5 exposure was significantly associated with an increased risk of colorectal cancer (HR = 1.27; 95% CI = 1.17–1.37 per 5 μg/m3 increase). Five independent susceptibility loci reached statistical significance at P < 1.22 × 10−8 in the interaction analysis. Furthermore, a joint interaction was observed between PM2.5 exposure and the PRS based on these five loci with colorectal cancer risk (P = 3.11 × 10−29). The Gene Ontology analysis showed that the vascular endothelial growth factor (VEGF) receptor signaling pathway was involved in the biological process of colorectal cancer. Conclusions: Our large-scale analysis has shown for the first time that long-term PM2.5 exposure potential increases colorectal cancer risk, which might be modified by genetic variants.
first_indexed 2024-12-21T12:59:53Z
format Article
id doaj.art-3dabaab72e8e4100a1777b03409c6ff6
institution Directory Open Access Journal
issn 0160-4120
language English
last_indexed 2024-12-21T12:59:53Z
publishDate 2021-02-01
publisher Elsevier
record_format Article
series Environment International
spelling doaj.art-3dabaab72e8e4100a1777b03409c6ff62022-12-21T19:03:13ZengElsevierEnvironment International0160-41202021-02-01147106309A prospective study of the associations among fine particulate matter, genetic variants, and the risk of colorectal cancerHaiyan Chu0Junyi Xin1Qi Yuan2Yanling Wu3Mulong Du4Rui Zheng5Hanting Liu6Shaowei Wu7Zhengdong Zhang8Meilin Wang9Department of Environmental Genomics, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China; Department of Genetic Toxicology, The Key Laboratory of Modern Toxicology of Ministry of Education, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, ChinaDepartment of Environmental Genomics, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China; Department of Genetic Toxicology, The Key Laboratory of Modern Toxicology of Ministry of Education, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, ChinaDepartment of Environmental Genomics, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, ChinaDepartment of Environmental Genomics, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, ChinaDepartment of Environmental Genomics, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, ChinaDepartment of Environmental Genomics, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, ChinaDepartment of Environmental Genomics, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, ChinaDepartment of Occupational and Environmental Health Sciences, School of Public Health, Peking University, Beijing, ChinaDepartment of Environmental Genomics, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China; Department of Genetic Toxicology, The Key Laboratory of Modern Toxicology of Ministry of Education, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China; Corresponding authors at: Department of Environmental Genomics, School of Public Health, Nanjing Medical University, 101 Longmian Avenue Jiangning District, Nanjing 211166, China.Department of Environmental Genomics, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China; Department of Genetic Toxicology, The Key Laboratory of Modern Toxicology of Ministry of Education, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China; Corresponding authors at: Department of Environmental Genomics, School of Public Health, Nanjing Medical University, 101 Longmian Avenue Jiangning District, Nanjing 211166, China.Background: Fine particulate matter (PM2.5) is suspected to increase the risk of colorectal cancer, but the mechanism remains unknown. We aimed to investigate the association between PM2.5 exposure, genetic variants and colorectal cancer risk in the Prostate, Lung, Colon and Ovarian (PLCO) Cancer Screening trial. Methods: We included a prospective cohort of 139,534 cancer-free individuals from 10 United States research centers with over ten years of follow-up. We used a Cox regression model to assess the association between PM2.5 exposure and colorectal cancer incidence by calculating the hazard ratio (HR) and 95% confidence interval (CI) with adjustment for potential confounders. The polygenic risk score (PRS) and genome-wide interaction analysis (GWIA) were used to evaluate the multiplicative interaction between PM2.5 exposure and genetic variants in regard to colorectal cancer risk. Results: After a median of 10.43 years of follow-up, 1,666 participants had been diagnosed with colorectal cancer. PM2.5 exposure was significantly associated with an increased risk of colorectal cancer (HR = 1.27; 95% CI = 1.17–1.37 per 5 μg/m3 increase). Five independent susceptibility loci reached statistical significance at P < 1.22 × 10−8 in the interaction analysis. Furthermore, a joint interaction was observed between PM2.5 exposure and the PRS based on these five loci with colorectal cancer risk (P = 3.11 × 10−29). The Gene Ontology analysis showed that the vascular endothelial growth factor (VEGF) receptor signaling pathway was involved in the biological process of colorectal cancer. Conclusions: Our large-scale analysis has shown for the first time that long-term PM2.5 exposure potential increases colorectal cancer risk, which might be modified by genetic variants.http://www.sciencedirect.com/science/article/pii/S0160412020322649PM2.5Genetic variantsColorectal cancerInteraction
spellingShingle Haiyan Chu
Junyi Xin
Qi Yuan
Yanling Wu
Mulong Du
Rui Zheng
Hanting Liu
Shaowei Wu
Zhengdong Zhang
Meilin Wang
A prospective study of the associations among fine particulate matter, genetic variants, and the risk of colorectal cancer
Environment International
PM2.5
Genetic variants
Colorectal cancer
Interaction
title A prospective study of the associations among fine particulate matter, genetic variants, and the risk of colorectal cancer
title_full A prospective study of the associations among fine particulate matter, genetic variants, and the risk of colorectal cancer
title_fullStr A prospective study of the associations among fine particulate matter, genetic variants, and the risk of colorectal cancer
title_full_unstemmed A prospective study of the associations among fine particulate matter, genetic variants, and the risk of colorectal cancer
title_short A prospective study of the associations among fine particulate matter, genetic variants, and the risk of colorectal cancer
title_sort prospective study of the associations among fine particulate matter genetic variants and the risk of colorectal cancer
topic PM2.5
Genetic variants
Colorectal cancer
Interaction
url http://www.sciencedirect.com/science/article/pii/S0160412020322649
work_keys_str_mv AT haiyanchu aprospectivestudyoftheassociationsamongfineparticulatemattergeneticvariantsandtheriskofcolorectalcancer
AT junyixin aprospectivestudyoftheassociationsamongfineparticulatemattergeneticvariantsandtheriskofcolorectalcancer
AT qiyuan aprospectivestudyoftheassociationsamongfineparticulatemattergeneticvariantsandtheriskofcolorectalcancer
AT yanlingwu aprospectivestudyoftheassociationsamongfineparticulatemattergeneticvariantsandtheriskofcolorectalcancer
AT mulongdu aprospectivestudyoftheassociationsamongfineparticulatemattergeneticvariantsandtheriskofcolorectalcancer
AT ruizheng aprospectivestudyoftheassociationsamongfineparticulatemattergeneticvariantsandtheriskofcolorectalcancer
AT hantingliu aprospectivestudyoftheassociationsamongfineparticulatemattergeneticvariantsandtheriskofcolorectalcancer
AT shaoweiwu aprospectivestudyoftheassociationsamongfineparticulatemattergeneticvariantsandtheriskofcolorectalcancer
AT zhengdongzhang aprospectivestudyoftheassociationsamongfineparticulatemattergeneticvariantsandtheriskofcolorectalcancer
AT meilinwang aprospectivestudyoftheassociationsamongfineparticulatemattergeneticvariantsandtheriskofcolorectalcancer
AT haiyanchu prospectivestudyoftheassociationsamongfineparticulatemattergeneticvariantsandtheriskofcolorectalcancer
AT junyixin prospectivestudyoftheassociationsamongfineparticulatemattergeneticvariantsandtheriskofcolorectalcancer
AT qiyuan prospectivestudyoftheassociationsamongfineparticulatemattergeneticvariantsandtheriskofcolorectalcancer
AT yanlingwu prospectivestudyoftheassociationsamongfineparticulatemattergeneticvariantsandtheriskofcolorectalcancer
AT mulongdu prospectivestudyoftheassociationsamongfineparticulatemattergeneticvariantsandtheriskofcolorectalcancer
AT ruizheng prospectivestudyoftheassociationsamongfineparticulatemattergeneticvariantsandtheriskofcolorectalcancer
AT hantingliu prospectivestudyoftheassociationsamongfineparticulatemattergeneticvariantsandtheriskofcolorectalcancer
AT shaoweiwu prospectivestudyoftheassociationsamongfineparticulatemattergeneticvariantsandtheriskofcolorectalcancer
AT zhengdongzhang prospectivestudyoftheassociationsamongfineparticulatemattergeneticvariantsandtheriskofcolorectalcancer
AT meilinwang prospectivestudyoftheassociationsamongfineparticulatemattergeneticvariantsandtheriskofcolorectalcancer